GBp 8.25
(-4.07%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Operating Expenses | 242.69 Thousand | 159.68 Thousand | 172.46 Thousand | 207.63 Thousand | 39.33 Thousand |
Selling, General and Administrative Expenses | 242.69 Thousand | 159.68 Thousand | 172.46 Thousand | 207.63 Thousand | 39.33 Thousand |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | - | - | - | - |
Cost and Expenses | 242.69 Thousand | 159.68 Thousand | 172.46 Thousand | 207.63 Thousand | 39.33 Thousand |
Operating Income | -242.69 Thousand | -159.68 Thousand | -172.46 Thousand | -207.63 Thousand | -39.34 Thousand |
Interest Expense | - | 18.00 | 292.00 | - | - |
Income Tax Expense | - | - | - | - | - |
Earnings before Tax | -242.53 Thousand | -159.47 Thousand | -172.76 Thousand | -207.61 Thousand | -39.33 Thousand |
Net Income | -242.53 Thousand | -159.47 Thousand | -172.76 Thousand | -207.61 Thousand | -39.33 Thousand |
Earnings Per Share Basic | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 |
Earnings Per Share Diluted | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 |
Weighted Average Shares Outstanding | 6.4 Million | 32.04 Million | 32.04 Million | 30.28 Million | 14.55 Million |
Weighted Average Shares Outstanding (Diluted) | 6.4 Million | 32.04 Million | 32.04 Million | 30.28 Million | 14.55 Million |
Gross Margin | - | - | - | - | - |
EBIT Margin | - | - | - | - | - |
Profit Margin | - | - | - | - | - |
EBITDA | -242.53 Thousand | -159.46 Thousand | -172.46 Thousand | -207.61 Thousand | -39.34 Thousand |
Earnings Before Tax Margin | - | - | - | - | - |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 44.13 Thousand | - | - | - | - | - |
Gross Profit | -44.13 Thousand | - | - | - | - | - |
Operating Expenses | 2.85 Million | 242.69 Thousand | 170.97 Thousand | 71.72 Thousand | 91.42 Thousand | 159.68 Thousand |
Selling, General and Administrative Expenses | 2.85 Million | - | 170.97 Thousand | 71.72 Thousand | 91.42 Thousand | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 2.9 Million | 242.69 Thousand | 170.97 Thousand | 71.72 Thousand | 91.42 Thousand | 159.68 Thousand |
Operating Income | -2.9 Million | -242.69 Thousand | -170.97 Thousand | -71.72 Thousand | -91.42 Thousand | -159.68 Thousand |
Interest Expense | 402.94 Thousand | - | - | - | - | 18.00 |
Income Tax Expense | 133.00 | - | - | - | - | - |
Earnings before Tax | -3.3 Million | -242.53 Thousand | -170.89 Thousand | -71.63 Thousand | -90.92 Thousand | -159.47 Thousand |
Net Income | -3.3 Million | -242.53 Thousand | -170.89 Thousand | -71.63 Thousand | -90.92 Thousand | -159.47 Thousand |
Earnings Per Share Basic | -0.10 | - | -0.03 | -0.01 | -0.01 | - |
Earnings Per Share Diluted | -0.10 | - | -0.03 | -0.01 | -0.01 | - |
Weighted Average Shares Outstanding | 33.33 Million | 6.4 Million | 6.4 Million | 6.4 Million | 6.4 Million | 32.04 Million |
Weighted Average Shares Outstanding (Diluted) | 33.33 Million | 6.4 Million | 6.4 Million | 6.4 Million | 6.4 Million | 32.04 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -2.85 Million | - | -170.97 Thousand | -71.72 Thousand | -91.42 Thousand | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
FVJ
NEULANDLAB
AZZTF
GWIN
1463
NIVAKA